Viewing Study NCT00696332


Ignite Creation Date: 2025-12-24 @ 9:29 PM
Ignite Modification Date: 2025-12-25 @ 7:14 PM
Study NCT ID: NCT00696332
Status: COMPLETED
Last Update Posted: 2011-10-21
First Post: 2008-06-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Talampanel for Amyotrophic Lateral Sclerosis (ALS)
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module